The findings come as real-world data shows around half of people discontinue GLP-1 receptor agonist treatment within 12 months, and just months after NICE published quality standards recommending post-treatment support for at least one year
No dosing or clinical guidance is provided or implied
I see patients who are really sick autoimmune conditions, toxic overload, chronic inflammation, neurological issues
From medical history review to dosage planning and follow-up assessments, each step is designed to ensure safe and effective outcomes
even healthy fats are calorie-dense, and semaglutide increases sensitivity to overconsumption
prevented type 2 diabetes progression over five years saves $10,000 in drug and complication costs